Resources

Explore how the ISR Platform^® can effectively de-risk your injectable therapeutic candidates today!

Discover a quick approach to de-risk your injectable therapeutic candidates using ex vivo live human skin.

Explore InflammaSkin^®, a unique T cell-driven skin inflammation platform to test your topical anti-psoriasis formulas.

Uncover InflammaSkin^®, a unique T cell-driven skin inflammation platform to test your injecatble anti-psoriasis formulas.

Ask the Expert: Your Top Questions About Genoskin’s Mast Cell Platform Answered Curious about mast cells and their role in injection site reactions? Learn about how Genoskin sources and cultures human primary mast cells, the unique qualities of our mast cell research solution, and its diverse applications in drug toxicity assessment, allergic reaction evaluation, and vaccine development. 1. How doRead more

Assessment of injection site reactionsA new proprietary research tool to identify drug-related immune adverse reactions in human skinToday, biologics represent one of the fastest growing markets within the pharmaceutical industry.The pipeline of biological drugs is growing at a rapid pace with a global market expected to reach over 460 billion USD in 2024 (1). In order to bypass gastric metabolism,Read more